Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol for Iron Deficiency Anemia in Pediatric Subjects
NCT03893045Phase 3Recruiting
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Sep 2019
- Primary completion
- Jul 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by AMAG Pharmaceuticals, Inc.. Started Sep 2019; status: recruiting.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03893045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893045.